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Abstract   
Background: Paracetamol or acetaminophen is active metabolites of phenacitin. It is a widely used 
over-the-counter analgesic and antipyretic. Chemically, it is 4-hydroxy acetanilide 
(acetaminophen). Paracetamol is approved for reducing fever in people of all ages. It is commonly 
used for the relief of headaches, other minor aches and pains, and is a major ingredient in 
numerous cold and flu remedies. Many different brands and dosage forms of paracetamol are 
available in Yemeni market that places health practitioners in a dilemma of drug substitution in 
case of non-availability of a particular brand.  
Aim/Objective:  The aim of the present study was to evaluate the quality control of four brands of 
paracetamol tablets (500 mg) marketed and commonly prescribed in Yemeni market. The results 
and findings of the present study will be interpreted and discussed. 
Materials and methods: Four brands of paracetamol tablets (500 mg) were purchased from the 
retail pharmacy outlets and their pharmaceutical quality were assessed by using in-vitro tests 
according to USP and BP standards and unofficial standards as recommended by the 
manufacturers. The assessment of tablets included the evaluation of uniformity of weight, hardens, 
friability, disintegration time, dissolution test as well as assay content by UV spectrophotometric 
method. 
Results: All brands passed USP and BP standards in- vitro quality control tests prescribed for the 
tablets except hardens test but all products were satisfactory for hardness. 
Conclusion: The results indicated that the overall quality of all tested paracetamol tablets brands 
was satisfactory as they met the requirements of the official and unofficial quality control tests. 
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1. Introduction 
Paracetamol or acetaminophen is active metabolites of phenacitin (figure 1). It is a widely 
used over-the-counter analgesic and antipyretic. Chemically, it is 4-hydroxy acetanilide 
(acetaminophen) [1].         







Figure 1. Chemical structure of Paracetamol 
Paracetamol is approved for reducing fever in people of all ages. It is commonly used for 
the relief of headaches, other minor aches and pains, and is a major ingredient in numerous cold 
and flu remedies [2]. 
It is classified as a non-steroidal anti-inflammatory drug (NSAID) by some sources [3], and 
not as an NSAID by others [4], while most sources implicitly distinguish them, for example by 
mentioning both NSAIDs and paracetamol in the same sentence [5 - 6]. Paracetamol has few anti-
inflammatory effects in comparison to NSAIDs. 
  
Paracetamol is available in different dosage form: tablet, capsules, drops, elixirs, 
suspension and suppositories. Dosage form of paracetamol and its combinations with other drugs 
have been listed in various pharmacopoeias [7 - 8].
 
 
Quality of the drug according to the modern definition requires that the product contain the 
quantity of each active ingredient claimed on its label within the applicable limits of its 
specifications, contain the same quantity of active ingredient from one dosage unit to the next, be 
free from extraneous substances, maintain its potency, therapeutic availability and appearance until 
used, and upon administration release active ingredient for full biological availability [9]. 
Poor quality medicines do not meet official standard for strength, quality, purity, packaging 
and labeling [10]. 
Most researchers investigating stated content of paracetamol have utilized HPLC assay that 
was used as an accurate, simple, reproducible and sensitive method for the determination of 
paracetamol in tablet formulation [11]. 
UV-Visible spectrophotometry is one of the most frequently employed technique in 
pharmaceutical analysis. It involves measuring the amount of ultraviolet or visible radiation 
absorbed by a substance in solution. Instrument which measure the ratio, or function of ratio, of the 
intensity of two beams of light in the U.V-Visible region are called Ultraviolet-Visible 
spectrophotometers [12]. 
In present study a quality control for a Paracetamol from different manufacturing sources in 
Yemeni market was investigated. 
 
2. Materials and Methods  
2.1.Material 
This study is based on the comparison of available paracetamol 500 mg tablets brands in 
Yemeni market that are available for consumer use. Four brands of drug were taken that are coded 
accordingly as A, B, C, and D (table 1), and assessed using the quality control parameters of 
weight uniformity, hardness, friability, disintegration time, dissolution profile and active ingredient 
content. The labeled shelf life of all of the tablets was three years from the date of manufacturing 
and was taken for the evaluation before two years of the labeled expiry date. The evaluation was 
done according to USP and British pharmacopoeia (BP) standards. 
Table 1. Different brands of Paracetamol tablets. 
Batch no. Country of origin Dosage form Code 
979121 Ireland tablet A 
122378 Egypt tablet B 
9277 U.A.E tablet C 
2909 U.A.E tablet D 
 
2. Methodology   
Various analytical methods and tests are important for the development and manufacture of 
pharmaceutical formulations. The evaluation was done according to USP and BP standards. 
2.1 Weight Variation 
Tablets of each brand were weighed individually using a digital analytical balance Shimadzu. The 
percentage deviation of the individual tablets from the mean was determined according to USP. 
2.2 Hardness Test 
A tablet was placed vertically on the Monsanto Hardness tester. The load was then applied along 
the radial axis of the tablet. The weight or load required for breaking the tablet was noted down. 
  
Similarly it was done for 10 tablets. 
2.3 Friability 
It was performed using Roche Friabilator, 10 tablets were weighed and placed in apparatus. The 
apparatus was rotated at a speed of 25 rpm. The apparatus was made to rotate for 4 min. The 
tablets were then weighed and the weights were compared with the initial weights. The % friability 
was calculated using the formula. 
% F = [1 - (W/Wo)] x 100 Where, % F = Friability in %, Wo = Initial weight of tablets, W = 
Weight of the tablets after revolution. 
2.4 Tablet Disintegration 
It was performed using Electro Lab disintegration apparatus, 6 tablets were placed in disintegration 
test apparatus. It was maintained at 37 ± 0.2
o
C containing simulated gastric fluid (0.1N HCl). 
Noted down the time taken for tablets to disintegrate. 
2.5 Dissolution Test 
For this test USP Type-1 (Basket) 6 Paddle Apparatus was used. The tablets formed were 
immersed into 900 mL. of dissolution medium, simulated gastric fluid (0.1N HCl). The 
temperature of the dissolution medium was maintained at 37 ± 0.2
o
C. The basket was rotated at a 
speed of 150 rpm. After an interval of every 10 minutes, 2 mL. of the medium was pipette out and 
replaced with fresh medium (0.1N HCl). This was continued all along for one hour. The pipetted 
out samples were then diluted to 10 mL. with fresh dissolution medium and were then filtered. The 
absorbances of the filtered samples were determined using U.V. Spectroscopy at λ max 222 nm. 
According to USP [13] specifications not less than 80% (Q) of the labeled amount of 
acetaminophen is dissolved within 30 minutes. 
2.6.Assay Paracetamol 
Weigh and powdered 20 tablets accurately a quantity of powder equivalent to 0.15 gms of 
paracetamol and 50 mL of 0.1M NaOH, diluted with 100 mL of water, shacked for 15 minutes and 
add sufficient water to produce 200 mL mixed and filtered and diluted 10 mL of filtrate to 100 mL 
with water. To 10 mL of resulting solution add 10 mL of 0.1 M NaOH dilute to 100 mL with water 
and measure the absorbance of the resulting solution at about 257 nm. Assay content for 
paracetamol was carried out by measuring the absorbance of the sample at 257 nm using Shimadzu 
1240 UV visible spectrophotometer, Japan and comparing the content from a calibration curve 
prepared with standard paracetamol in the same medium. An accurately weighed quantity of this 
powder was taken, suitably dissolved in pH 5.8 phosphate buffer, making dilution and analyzed 
and carried out in triplicate and mean was taken. The concentration of each sample was also 
determined using Beer Lambert’s law according to BP [14]. 
2.7.Data processing and analysis 
After the completion of all test procedures data for all the individual tablets were recorded and 
separated on a different sheets according to the manufacturer. Finally data were analyzed by using 
the above mentioned mathematical formula and MS-Excel®, 2007. 
 
3. RESULTS AND DISCUSION:  
During this research standard books and procedure were used to conduct each test. Among 
the books BP [15] and USP [16] were widely used. The degree of tolerance was also taken from the 
two pharmacopeias. A total of 6 Paracetamol brand marketed in Somali region were screened for 
weight variation, friability, disintegration time, identification and content uniformity. 
3.1 Average Weight and Weight Variation 
The average weight and weight variation of the different brands of paracetamol tablets 
tested are shown in Tables 3.1 and Fig.3.1. It was found that the average weight of different four 
  
brands tablets of paracetamol ranged from 566.3 mg  0.912 % to 668.38 mg  0.944 %. 
According to official books, the specified limit on weight variation for tablets more than 324 mg is 
± 5 %. It was found that all the tablets passed the USP specifications for weight variation as none 
of the brands deviated by upto ±5% from the mean value. This indicates that the factors leading to 
weight variation were taken in consideration. Also, the very small %RSD values of weight 
variation prove the high homogeneity of the tablets produced and shown high efficiency of weight 
uniformity and weight distribution.   Weight variation gives a rough idea of content uniformity, but 
not a confirmatory test. On the other hand, there were differences in the weight of tablet even 
though all tablets contain 500 mg active. A possible explanation for this might be that different 
excipients used for the manufacturing which are increasing or reducing the weight of the tablet 
[17]. 
 
Table 2. Average weight, % deviation from average weight, content uniformity, % 
deviation from content uniformity, hardness (kg/cm
2
) and % deviation from hardness of 
different brands of paracetamol tablets.     
Brands 
Average weight (mg) , 
% RSD   
Content uniformity (%),  
% RSD  
Hardness (kg/cm
2
) ,  
% RSD   
A 668.38 ± 0.944 98.3 %  ± 2.52 13.67 ± 2.44 
B 613  ± 0.498 97.25  %  ± 1.26 26.075 ± 13.33393 
C 640.79  ± 0.616 98.2 %  ± 0.44 19.57 ± 2.348 
D 566.3  ± 0.912 99.15 %  ± 0.966 15.765 ± 8.506 
  
Figure 2. Comparison of different brands weight variation of different brands of paracetamol tablets. 
3.2. Content Uniformity (Assay) 
Test for percentage of content is based on the assay of the individual content of active 
ingredient of a number of single dose units. The average chemical content (assay) values of the 
different brands of paracetamol tablets tested are shown in table 2 and Figure3. The results of the 
assay of chemical content of paracetamol tablets showed that the active content of all the brands 
were between 97.25 % (B brand) and 99.15 % (D brand) of the labeled amount specified for 
paracetamol. According to the United State Pharmacopoeia [18], a paracetamol tablet should 
contain not less than 90% (450 mg) and not more than 110 % (550 mg) of paracetamol. The results 
indicated that although different manufacturer formulates the different brands are under the 
BP/USP specification [19]. The results indicated that although different manufacturer formulates 
the different brands are under the BP/USP specification [19]. There was no statistically significant 
difference between the different brands of the paracetamol tablets. Furthermore, all the brands of 




 Fig.3. Comparison of assay content (Percent %) of different brands of paracetamol tablet. 
 
3.3 Hardness 
In the pharmaceutical industry, hardness of the tablets is an important parameter because 
pharmaceutical tablets must have sufficient ability to survive the handling forces during packaging 
and shipping. The average values of hardness of the different brands of paracetamol tablets tested 
are shown in table 2 and figure 4. The results indicated that, the average values of hardness of the 
different brands of paracetamol tablets tested were in the range 13.67 kg/cm
2
 – 26.075 kg/cm2. In 
the study, all brands of paracetamol tablets were above the limit range of between 4 to 10 kg/cm
2  
stated [20, 21]. High crushing strength is attributed to a high compression force, high binder 
concentration or excess volume of granulating fluid [22]. This related to one or combined factors 
affect on hardness. Although all uncoated brands of Paracetamol tablets have very high hardness, 
they still exhibited very good quality control parameters such as dissolution profile, disintegration 
time and chemical content determination. This indicates that hardness test is not a critical quality 
control parameter [23]. 
 
Figure 4. Comparison of hardness of different brands of paracetamol tablet. 
 
3.4. Friability Test: 
Friability is another important parameter that is related to hardness, disintegration and 
dissolution. The average values of friability of the different brands of paracetamol tablets tested are 
shown in Table 3 and Figure 5. The results indicated that all of the tablet samples tested showed 
impressive friability values ranging from 0.063 % (A brand) to 0.22 % (D brand). According to the 
USP [18] the allowed limit of friability is not more than 1.0 % of weight Loss. In all formulations 
  
the percent (%) friability was less than 1% and as such all the brands of paracetamol had passed 
this friability specification. This indicated that all the tablets of each brand were mechanically 
stable [24]. 
 
Table 3. Friability percent (%), disintegration time (min), dissolution (30 min), % 
deviation from dissolution of different brands of paracetamol tablet     
Brands    Friability   (%)    Disintegration time (min) Dissolution (min), % RSD     
A 0.063 2.00 101.58 % ± 1.21 
B 0.18 14.1 95.5 % ± 0.980  
C 0.153 3.00 98.18 % ± 0.798 




Figure 5. Comparison of friability percent (%) of different brands of paracetamol tablet. 
3.5. Disintegration Time: 
Tablet disintegration time is one of the very important physicochemical properties in solid 
dosage forms. The disintegration test measures the time required for tablets to disintegrate into 
particles. This is a necessary condition for dissolution and could be the rate-determining step in the 
process of drug absorption. The average values of disintegration of the different brands of 
paracetamol tablets tested are shown in table 3 and figure 6. The highest disintegration time (14.10 
min) was observed for B brand, while the lowest disintegration time (2.00 min) was observed for A 
brand. That is, a brand quickly disintegrated compared to other brands, with disintegration time of 
2.00 min. The result showed that disintegration time of all the selected tablets was found to be 
within specified limits of USP and BP. According to BP [25], which specifies 15 minutes as 
disintegration time whereas uncoated USP tablets have disintegration time standards as low as 5 




Figure 6. Comparison of disintegration time (min) of different brands of paracetamol tablet. 
3.6. Dissolution Test 
Dissolution was another studied important quality control parameters directly related to the 
absorption and bioavailability of drug.  Also, dissolution behaviour of a drug has a significant 
effect on their pharmacological activity. In fact, a direct relationship between in vitro dissolution 
rate of many drugs and their bioavailability has been demonstrated and is generally referred to as in 
vitro – in vivo correlation [26]. Drugs with poor dissolution profile will not be available in the 
body system or target organ/tissue to elicit therapeutic effect. The average values of dissolution of 
the different brands of paracetamol tablets tested are shown in table 3 and figure 7. Tablet 
dissolution in 30 minutes ranged from 95.5 % to 101.58 %.  All brands of showed more than 90 % 
drug release after 30 minutes. Dissolution of the all the selected brands of paracetamol tablets was 
found to be within the specified limits of not less than 80 % in 30 min (USP) [18] and not less than 
70% (BP) [14]. All brands of paracetamol tablets achieved this standard. This might be as a result 
of strict adherence to good manufacturing practice in the process of manufacturing these tablets. 
 
 
Figure 7. Comparison of dissolution test of different brands of paracetamol tablet. 
 









%RSD  friability   




(30 min)  
A 668.38 (±0.944) 98.3 (±2.52) 13.67 (±2.44) 0.063 2.00 101.58 (±1.21) 
B 613 (±0.498) 97.25 (±1.258) 26.075 (±13.334) 0.18 14.1 95.5 (±0.980) 
C 640.8 (±0.6157) 98.2 (±0.44) 19.57 (±2.348) 0.153 3.00 98.18 (±0.798) 




The in-vitro physical and chemical evaluation of selected commercial brands of 
paracetamol available in Yemeni market proved the quality and efficacy according to the standards 
of USP and BP requirements. Paracetamol is a prescription drug, Hence, it is essential that it is 
manufactured following Good Manufacturing Practice (GMP). In this study, it was observed that 
all the formulation complied with the specification. It is also important that the tablets meet all the 
parameters because all are essential.  All four brands of the paracetamol tablet comply with BP and 
USP specifications for in vitro quality control tests of uniformity of weight, uniformity of content, 
friability, disintegration time, and dissolution except hardens test (see table 3.3). The USP and BP 
specification of maximum hardens value of 10 kg/cm
2
, where the lower value of hardens is 13.67 
kg/cm
2
 and the value is 26.075 kg/cm
2
. But Hardness is referred to as non-compendial test.  
 If the hardness is increased, then the disintegration rate will increase and this will affect the 
dissolution profile. It is also necessary that the drugs disintegrate properly because this will 
influence the dissolution profile. Pharmaceutical equivalence can also be determined from these 
tests. According to my knowledge, not much work has been done to determine the quality control 
parameters of generic paracetamol tablet available in market. So further study needs to be 
conducted regarding the quality control parameters because paracetamol is widely used by people 
and it is necessary that the product is of good and acceptable quality. 
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